MI

Global Contrast Media Injectors Market Research Report 2023: Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 16, 2023

The "Contrast Media Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Contrast Media Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The report also offers an extensive analysis of the competitive landscape within the global contrast media injectors market.
  • Contrast Media Injectors Market Trends:
    The global contrast media injectors market is experiencing robust growth driven by various factors.
  • What is the breakup of the global contrast media injectors market based on the end user?

Sierra Metals Closes $16.4 million Private Placement

Retrieved on: 
Friday, October 13, 2023

Sierra Metals Inc. (TSX: SMT; OTC: SMTSF) (“Sierra Metals” or the “Company”) is pleased to announce that it has closed a non-brokered private placement (the “Private Placement”) to issue 43,107,360 common shares of the Company (“Common Shares”) at a price of $0.38 per common share for aggregate gross proceeds of $16,380,796.80, a portion of which has closed in escrow.

Key Points: 
  • Sierra Metals Inc. (TSX: SMT; OTC: SMTSF) (“Sierra Metals” or the “Company”) is pleased to announce that it has closed a non-brokered private placement (the “Private Placement”) to issue 43,107,360 common shares of the Company (“Common Shares”) at a price of $0.38 per common share for aggregate gross proceeds of $16,380,796.80, a portion of which has closed in escrow.
  • Insiders of the Company (the “Participating Insiders”) participated in the Private Placement for an aggregate amount of 2,361,453 Common Shares.
  • Further information regarding the Private Placement will be provided in a material change report to be filed by the Company.
  • The Private Placement was among the alternatives considered by Sierra Metals as part of the Company’s strategic review process conducted with the assistance of CIBC Capital Markets.

Almonty Placement of Common Share Units and CDI’s raises C$500,000, US$733,333 and A$550,000

Retrieved on: 
Friday, October 6, 2023

Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) is pleased to announce that the Company has received firm commitments to raise gross proceeds of C$500,000, US$733,333 and A$550,000 via the issuance of 3,333,333 Placement Units and 1,078,433 million Placement Chess Depository Interests Units (“CDIs”) at C$0.45 per Placement Unit, US$0.33 per Placement Unit and A0.51 per CDI Unit (“Placement”).

Key Points: 
  • Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) is pleased to announce that the Company has received firm commitments to raise gross proceeds of C$500,000, US$733,333 and A$550,000 via the issuance of 3,333,333 Placement Units and 1,078,433 million Placement Chess Depository Interests Units (“CDIs”) at C$0.45 per Placement Unit, US$0.33 per Placement Unit and A0.51 per CDI Unit (“Placement”).
  • Lewis Black, the Company’s CEO will be investing C$500,000 and Dan D’Amato, a director of the Company, will be investing US$366,666.63 towards the Placement Units to be issued.
  • The Placement Units and Placement CDI’s issued will rank equally with existing CDI’s and Common Shares on issue.
  • Lewis Black, CEO of the Company, and Daniel D’Amato, a Director of the Company, will be subscribing for Units in the Private Placement.

Shimadzu Medical Systems USA installs first TRINIAS SCORE OPERA Cardiac Catheterization Lab in the US

Retrieved on: 
Friday, October 13, 2023

LONG BEACH, Calif., Oct. 13, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12 (ceiling-mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).

Key Points: 
  • LONG BEACH, Calif., Oct. 13, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12 (ceiling-mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).
  • Shimadzu Medical Systems USA, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12!
  • Beaufort Memorial Hospital marked the 20th anniversary of the Cochrane Heart Center with the opening of its newly renovated cardiac catheterization lab outfitted with the most advanced technology in the nation.
  • These patients require an urgent, minimally invasive stenting procedure called percutaneous coronary intervention (PCI) that is performed in the cath lab.

IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt

Retrieved on: 
Friday, October 13, 2023

"There are no words to describe the scale of the horrors that are starting to come to light.

Key Points: 
  • "There are no words to describe the scale of the horrors that are starting to come to light.
  • Israel is a small country, every single one of us is directly impacted, either personally or through our family and loved ones.
  • IMC supports and stands with all the Israelis that are affected by this war.
  • "In Israel, Cannabis is defined as a critical infrastructure sector, just like any other pharmaceutical business.

IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt

Retrieved on: 
Friday, October 13, 2023

"There are no words to describe the scale of the horrors that are starting to come to light.

Key Points: 
  • "There are no words to describe the scale of the horrors that are starting to come to light.
  • Israel is a small country, every single one of us is directly impacted, either personally or through our family and loved ones.
  • IMC supports and stands with all the Israelis that are affected by this war.
  • "In Israel, Cannabis is defined as a critical infrastructure sector, just like any other pharmaceutical business.

LOBOS 1707'S LIMITED EDITION AÑEJO TEQUILA IS BACK BY POPULAR DEMAND

Retrieved on: 
Wednesday, October 11, 2023

NEW YORK, Oct. 11, 2023 /PRNewswire/ -- Due to popular demand, Lobos 1707 Tequila & Mezcal has officially announced the additional availability of their Limited Edition Añejo tequila. Only available for a limited time with a small quantity at retailers and restaurants, this ultra-premium Lobos 1707 Limited Edition Añejo has increased availability, expanding to 28 U.S. markets with around 9,000 bottles total.

Key Points: 
  • IMAGES FOR USE CAN BE FOUND HERE (Credit: LOBOS 1707 TEQUILA & MEZCAL)
    NEW YORK, Oct. 11, 2023 /PRNewswire/ -- Due to popular demand, Lobos 1707 Tequila & Mezcal has officially announced the additional availability of their Limited Edition Añejo tequila.
  • Only available for a limited time with a small quantity at retailers and restaurants, this ultra-premium Lobos 1707 Limited Edition Añejo has increased availability, expanding to 28 U.S. markets with around 9,000 bottles total.
  • "We are thrilled to bring back the Lobos 1707 Limited Edition Añejo for those who have yet to experience this award-winning liquid for themselves."
  • The Lobos 1707 Limited Edition Añejo variant is the perfect pairing for elevated occasions, fine dining experiences and nightlife fun, or any celebration big and small.

Lexis® Everyfile, the New Firmwide Matter Management Solution to Meet the Demands of the Modern Law Firm

Retrieved on: 
Wednesday, October 11, 2023

The application provides a firmwide foundation to enable efficient legal service delivery for every matter.

Key Points: 
  • The application provides a firmwide foundation to enable efficient legal service delivery for every matter.
  • It is designed to manage the "missing middle" in a law firm's technology stack, inclusive of key matter metadata that is not captured in traditional PMS, DMS or CRM systems.
  • Document and template production is possible from within the application, which is seamlessly integrated into the firm's chosen document and email management solution.
  • "This solution has been developed based on direct insight into the challenges modern legal practices face.

Lexis® Everyfile, the New Firmwide Matter Management Solution to Meet the Demands of the Modern Law Firm

Retrieved on: 
Wednesday, October 11, 2023

The application provides a firmwide foundation to enable efficient legal service delivery for every matter.

Key Points: 
  • The application provides a firmwide foundation to enable efficient legal service delivery for every matter.
  • It is designed to manage the "missing middle" in a law firm's technology stack, inclusive of key matter metadata that is not captured in traditional PMS, DMS or CRM systems.
  • Document and template production is possible from within the application, which is seamlessly integrated into the firm's chosen document and email management solution.
  • "This solution has been developed based on direct insight into the challenges modern legal practices face.

WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING

Retrieved on: 
Wednesday, October 11, 2023

CALGARY, AB, Oct. 10, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients, is pleased to announce the completion of its previously announced offering of convertible debenture units of the Company (the "Debenture Units"), on a non-brokered private placement basis, for aggregate proceeds of C$800,000 (the "Offering").

Key Points: 
  • CALGARY, AB, Oct. 10, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients, is pleased to announce the completion of its previously announced offering of convertible debenture units of the Company (the "Debenture Units"), on a non-brokered private placement basis, for aggregate proceeds of C$800,000 (the "Offering").
  • The Offering was led by insiders including members of the Board of Directors and members of the senior management team of the Company, who subscribed for a total of C$515,000.
  • Each Debenture Unit consists of one 12% unsecured convertible debenture in the principal amount of C$1,000 (each, a "Convertible Debenture") with a maturity date of October 10, 2026 (the "Maturity Date") and 4,762 common share purchase warrants (each, a "Warrant").
  • The Convertible Debentures are convertible at the holder's option into Shares at any time prior to the earlier of the business day immediately preceding the Maturity Date and the date fixed for redemption of the Convertible Debentures at a conversion price of C$0.105 per Share.